2022 ICD-10-CM Code D25.9
Leiomyoma of uterus, unspecified
Valid for Submission
| ICD-10: | D25.9 |
| Short Description: | Leiomyoma of uterus, unspecified |
| Long Description: | Leiomyoma of uterus, unspecified |
Code Classification
D25.9 is a billable diagnosis code used to specify a medical diagnosis of leiomyoma of uterus, unspecified. The code D25.9 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D25.9 might also be used to specify conditions or terms like abnormal uterine bleeding due to uterine fibroid, antepartum hemorrhage with uterine leiomyoma, antepartum hemorrhage with uterine leiomyoma - not delivered, benign metastasizing leiomyoma of uterus, benign neoplasm of uterine cervix , bleeding from female genital tract during pregnancy, etc.
The code D25.9 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
Unspecified diagnosis codes like D25.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D25.9 are found in the index:
- - Fibroid (tumor) - See Also: Neoplasm, connective tissue, benign;
- - uterus - See Also: Leiomyoma, uterus; - D25.9
- - Leiomyofibroma - See Also: Neoplasm, connective tissue, benign;
- - uterus (cervix) (corpus) - D25.9
- - Leiomyoma - See Also: Neoplasm, connective tissue, benign;
- - uterus (cervix) (corpus) - D25.9
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Abnormal uterine bleeding due to uterine fibroid
- Antepartum hemorrhage with uterine leiomyoma
- Antepartum hemorrhage with uterine leiomyoma - not delivered
- Benign metastasizing leiomyoma of uterus
- Benign neoplasm of uterine cervix
- Bleeding from female genital tract during pregnancy
- Cervical fibroid
- Epithelioid leiomyoma of uterus
- Erythrocytosis due to uterine myoma
- Inappropriate secondary erythrocytosis
- Intracavitary leiomyoma of uterus
- Intrapartum hemorrhage
- Intrapartum hemorrhage due to leiomyoma
- Leiomyoblastoma of uterus
- Pedunculated leiomyoma of uterus
- Pelvic mass in pregnancy
- Polyp of corpus uteri
- Solitary uterine leiomyoma
- Torsion of uterine fibroid
- Uterine fibroid - baby delivered
- Uterine fibroid - baby delivered with postpartum complication
- Uterine fibroid affecting obstetric care
- Uterine fibroid complicating postpartum care - baby delivered during previous episode of care
- Uterine fibroid polyp
- Uterine fibroids affecting pregnancy
- Uterine fibroids in pregnancy, childbirth and the puerperium
- Uterine leiomyoma
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D25.9 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 742 | UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC | 13 | 1.717 |
| 743 | UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC | 13 | 1.1323 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D25.9 to ICD-9 Code
- 218.9 - Uterine leiomyoma NOS
Information for Patients
Uterine Fibroids
Uterine fibroids are the most common benign tumors in women of childbearing age. Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown. Risk factors include being African American or being overweight.
Many women with fibroids have no symptoms. If you do have symptoms, they may include
- Heavy or painful periods or bleeding between periods
- Feeling "full" in the lower abdomen
- Urinating often
- Pain during sex
- Lower back pain
- Reproductive problems, such as infertility, multiple miscarriages or early labor
Your health care provider may find fibroids during a gynecological exam or by using imaging tests. Treatment includes drugs that can slow or stop their growth, or surgery. If you have no symptoms, you may not even need treatment. Many women with fibroids can get pregnant naturally. For those who cannot, infertility treatments may help.
NIH: National Institute of Child Health and Human Development
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)